Antichlamydial activity of cervical secretion in different phases of the menstrual cycle and influence of hormonal contraceptives.

Abstract:

:Cervical secretion from three groups of asymptomatic women, either being oral contraceptive (OC) non-users or users (ethinylestradiol plus desogestrel or levonorgestrel), was tested for its capacity to prevent Chlamydia trachomatis, serotype I, from forming inclusions in cycloheximide-treated McCoy cells. The non-user groups were comprised of 12 women from whom cervical secretion was collected twice weekly during the menstrual cycle and 15 women from whom cervical secretion was collected once or twice weekly. The OC users included 66 women from whom cervical secretion was collected once or twice during their menstrual cycle. Cervical secretion from the non-users produced a decrease in the chlamydial inclusion count by 70%-90% during the first 3 weeks of the menstrual cycle, as compared with the fourth and fifth week when the reduction was 56%-68% (p < 0.001). Secretion from the OC users showed a more effective decrease in the inclusion count during the first 3 weeks of the menstrual cycle, as compared with samples obtained at the fourth and fifth weeks, i.e. 15%-35% vs. 20%-25% (p < 0.001). Cervical secretion of the non-users as compared to the users produced a significant decrease in the inclusion count, viz. 70%-90% vs. 15%-35% (p < 0.001) during the first 3 weeks as compared with 56%-68% vs. 20%-25% (p < 0.001) in the fourth or fifth week. The study suggests that natural resistance to genital chlamydial infection can differ during the menstrual cycle and it may be influenced by oral contraceptive use.

journal_name

Contraception

journal_title

Contraception

authors

Mahmoud EA,Hamad EE,Olsson SE,Mårdh PA

doi

10.1016/0010-7824(94)90044-2

subject

Has Abstract

pub_date

1994-03-01 00:00:00

pages

265-74

issue

3

eissn

0010-7824

issn

1879-0518

pii

0010-7824(94)90044-2

journal_volume

49

pub_type

杂志文章
  • Safety of intrauterine contraceptive device (copper T 200 B) in women with cardiac disease.

    abstract:BACKGROUND:Women with cardiac disease have need for effective long-lasting reversible contraception. Women with cardiac disease are at increased risk for bacterial endocarditis. There is limited research regarding the use of intrauterine contraceptive devices (IUD) in women with cardiac disease. STUDY DESIGN:In a pros...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章

    doi:10.1016/j.contraception.2008.05.006

    authors: Suri V,Aggarwal N,Kaur R,Chaudhary N,Ray P,Grover A

    更新日期:2008-10-01 00:00:00

  • Potential public sector cost-savings from over-the-counter access to oral contraceptives.

    abstract:OBJECTIVE:This study estimates how making oral contraceptive pills (OCPs) available without a prescription may affect contraceptive use, unintended pregnancies and associated contraceptive and pregnancy costs among low-income women. STUDY DESIGN:Based on published figures, we estimate two scenarios [low over-the-count...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2015.01.010

    authors: Foster DG,Biggs MA,Phillips KA,Grindlay K,Grossman D

    更新日期:2015-05-01 00:00:00

  • Effect of steroid hormones on the metabolism of human spermatozoa.

    abstract::Information relating to the effect of steroids on the metabolism and motility of human spermatozoa is limited despite the increasing interest in the use of these hormones for the purpose of contraception. In the present study it was shown that progesterone, testosterone, and 11-beta-OH-progesterone significantly inhib...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(81)90080-9

    authors: Trifunac NP,Bernstein GS

    更新日期:1981-05-01 00:00:00

  • Phase I prehysterectomy studies of the transcervical administration of quinacrine pellets.

    abstract::To determine the safety of transcervical administration of quinacrine pellets as a method of voluntary female sterilization, three noncomparative Phase I clinical trials of the administration of 250 mg quinacrine were carried out in 21 women who were scheduled to undergo hysterectomy 24 h or one month later. Detailed ...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章

    doi:10.1016/s0010-7824(96)00174-6

    authors: Laufe LE,Sokal DC,Cole LP,Shoupe D,Schenken RS

    更新日期:1996-09-01 00:00:00

  • Serum lipids in Chinese patients using oral contraceptive pills.

    abstract::Eighty-four Chinese patients attending the Family Planning Association of Hong Kong for contraception with oral contraceptive pills were randomized into 2 groups. The first group received pills containing 0.15 mg levonorgestrel and 0.03 mg ethinyl oestradiol. The second group received pills containing 0.15 mg desogest...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(90)90126-g

    authors: Ho PC,Liu WT,Kwan MS

    更新日期:1990-01-01 00:00:00

  • Doing more for less: identifying opportunities to expand public sector access to safe abortion in South Africa through budget impact analysis.

    abstract:OBJECTIVE(S):To estimate the costs of public-sector abortion provision in South Africa and to explore the potential for expanding access at reduced cost by changing the mix of technologies used. STUDY DESIGN:We conducted a budget impact analysis using public sector abortion statistics and published cost data. We estim...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2017.07.165

    authors: Lince-Deroche N,Harries J,Constant D,Morroni C,Pleaner M,Fetters T,Grossman D,Blanchard K,Sinanovic E

    更新日期:2018-02-01 00:00:00

  • Intrauterine contraception with copper and with levonorgestrel: a randomized study of the TCu 380Ag and levonorgestrel 20 mcg/day devices.

    abstract::First year results of a randomized study of 1509 users of the Copper T380Ag with a silver core or of an IUD releasing 20 mcg day of levonorgestrel are reported. The cumulative gross pregnancy rate for each device was 0.3 per 100 at one year, with more than 490 women having one year of use with each device. The levonor...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(84)90036-2

    authors: Sivin I,Alvarez F,Diaz J,Diaz S,el Mahgoub S,Coutinho E,Brache V,Diaz MM,Faundes A,Pavez M

    更新日期:1984-11-01 00:00:00

  • A comparison of tamoxifen and misoprostol to misoprostol alone for early pregnancy termination.

    abstract::A study was undertaken to determine whether the combination of oral tamoxifen and moistened misoprostol administered vaginally was superior to that of placebo and moistened misoprostol administered vaginally for elective termination of early pregnancies.A clinical trial was conducted with a study group of 150 healthy ...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/s0010-7824(99)00105-5

    authors: Jain JK,Meckstroth KR,Park M,Mishell DR Jr

    更新日期:1999-12-01 00:00:00

  • Corrosion behavior of Cu and the Cu-Zn-Al shape memory alloy in simulated uterine fluid.

    abstract::Chemical immersion tests, electrochemical methods and atomic absorption spectrometry were employed to investigate the corrosion behavior of Cu and the Cu-Zn-Al shape memory alloy (SMA) in simulated uterine fluid. The effect of pH on corrosion rate and corrosion potential was also investigated. The results indicated th...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2005.04.006

    authors: Chen B,Liang C,Fu D,Ren D

    更新日期:2005-09-01 00:00:00

  • Effect of a new contraceptive ring releasing 20 micrograms levonorgestrel daily on blood lipid levels and glucose tolerance.

    abstract::Fifteen healthy subjects used a contraceptive device, namely an intravaginal ring releasing 20 micrograms levonorgestrel daily, for 12 weeks. High, low and very low density fractions of cholesterol, triglyceride and phospholipids were measured, together with oral glucose tolerance before and after 12 weeks of use. The...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(84)90078-7

    authors: Elder MG,Lawson JP,Lucas S,Hamawi A,Trayner I,Fotherby K

    更新日期:1984-07-01 00:00:00

  • Comparison of medical abortion follow-up with serum human chorionic gonadotropin testing and in-office assessment.

    abstract:BACKGROUND:The study was conducted to compare lost to follow-up (LTFU) rates in women having a medical abortion who chose follow-up by in-office ultrasound assessment or serum beta human chorionic gonadotropin (β-hCG) testing. METHODS:This retrospective chart review included 865 women who underwent medical abortion in...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2011.09.007

    authors: Horning EL,Chen BA,Meyn LA,Creinin MD

    更新日期:2012-04-01 00:00:00

  • STS 557, a new orally active progestin with antiprogestational and contragestational properties in rabbits.

    abstract::STS 557 (17 alpha-cyanomethyl-17 beta-hydroxy-estra-4.9(10)-diene-3-one) is a potent progestin. This compound was 10 times as potent as the standard levonorgestrel as judged by the classic Clauberg-McPhail Assay. The antiprogestational response is significant when STS 557 treatment starts 2 days before progesterone ad...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(80)90140-7

    authors: Oettel M,Kurischko A

    更新日期:1980-01-01 00:00:00

  • Pilot study on the use of sublingual misoprostol in termination of pregnancy up to 7 weeks gestation.

    abstract:BACKGROUND:This study was conducted to assess the efficacy and incidence of side effects of a regimen of repeated doses of 400 microg sublingual misoprostol for termination of pregnancy of <7 weeks gestation. METHOD:Fifty women were given 400 microg sublingual misoprostol every 3 h for three doses. Two additional dose...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章

    doi:10.1016/s0010-7824(03)00134-3

    authors: Cheung W,Tang OS,Lee SW,Ho PC

    更新日期:2003-08-01 00:00:00

  • Menstrual induction with mifepristone and misoprostol.

    abstract::Menstrual induction refers to early uterine evacuation without laboratory confirmation of pregnancy in women with delayed menses. Mechanical aspiration is the method used in many countries but, as suggested by a pilot study, mifepristone followed by a prostaglandin analogue could also be effective. We launched the pre...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,多中心研究

    doi:10.1016/j.contraception.2003.09.009

    authors: Xiao B,von Hertzen H,Zhao H,Piaggio G

    更新日期:2003-12-01 00:00:00

  • Continuous oral low-dosage cyproterone acetate for fertility regulation in the male? A trend analysis in 15 volunteers.

    abstract::The effects of cyproterone acetate (CPA), administered orally in dos es of either 10 or 20 mg/day for 26 weeks, were studied in 15 healthy male volunteers. During treatment, there was a decrease in sperm density and in normal-shaped sperm and an increase in pathological and immature forms, an increase in dead spermat...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(76)90081-0

    authors: Koch UJ,Lorenz F,Danehl K,Ericsson R,Hasan SH,Keyserlingk DV,Lübke K,Mehring M,Römmler A,Schwartz U,Hammerstein J

    更新日期:1976-08-01 00:00:00

  • Effect of dose on the pharmacokinetics of levonorgestrel in the rat during the rapid elimination phase following subcutaneous administration.

    abstract::Adult female rats were given a single, subcutaneous injection of 8, 16 or 32 micrograms of levonorgestrel (LNG). Blood samples were collected at various time intervals and serum concentrations of LNG were determined by radioimmunoassay. The patterns of temporal decline in LNG concentrations in the three dose groups in...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(84)90009-x

    authors: Naqvi RH,Mitra SB,Lindberg MC

    更新日期:1984-12-01 00:00:00

  • Cervical carcinoma in situ and use of depot-medroxyprogesterone acetate (DMPA). WHO Collaborative Study of Neoplasia and Steroid Contraceptives.

    abstract::The relationship of depot-medroxyprogesterone acetate (D-MPA) use to risk of cervical carcinoma in situ was investigated using data from a large multi-national, hospital-based case-control study. To avoid possible detection bias from Pap smear screening, final analyses were restricted to a subset of cases with symptom...

    journal_title:Contraception

    pub_type: 杂志文章,多中心研究

    doi:10.1016/0010-7824(94)00007-j

    authors: Thomas DB,Ye Z,Ray RM

    更新日期:1995-01-01 00:00:00

  • Users' perspectives on implantable contraceptives for women.

    abstract::Users of subdermal contraceptive implants report long duration of use, convenience, and high efficacy as liked features and bleeding irregularities, weight loss/gain, and headaches as disliked effects of these methods. Satisfied users tend to be women who do not experience side effects or women who value positive feat...

    journal_title:Contraception

    pub_type: 杂志文章,评审

    doi:10.1016/s0010-7824(01)00281-5

    authors: Ortayli N

    更新日期:2002-01-01 00:00:00

  • Estimating systemic exposure to levonorgestrel from an oral contraceptive.

    abstract:OBJECTIVE:The gold standard for measuring oral contraceptive (OC) pharmacokinetics is the 24-h steady-state area under the curve (AUC). We conducted this study to assess whether limited sampling at steady state or measurements following use of one or two OCs could provide an adequate proxy in epidemiological studies fo...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2016.12.007

    authors: Basaraba CN,Westhoff CL,Pike MC,Nandakumar R,Cremers S

    更新日期:2017-04-01 00:00:00

  • Comparison of serum and cervical mucus hormone levels during hormone-free interval of 24/4 vs. 21/7 combined oral contraceptives.

    abstract:BACKGROUND:This study analyzes levels of progesterone, estradiol, norethindrone (NET) and ethinyl estradiol (EE) in serum and levels of NET in cervical mucus on the last day of the hormone-free interval (HFI) in users of 24/4 [norethindrone acetate (NETA)/EE-24] vs. 21/7 (NETA/EE-21) regimens. STUDY DESIGN:This was a ...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/j.contraception.2012.12.006

    authors: Fels H,Steward R,Melamed A,Granat A,Stanczyk FZ,Mishell DR Jr

    更新日期:2013-06-01 00:00:00

  • Histopathological and biochemical effects of gossypol acetate on pituitary-gonadal axis of male albino rats.

    abstract::Histopathological and biochemical effects of gossypol acetate (GA) on pituitary-gonadal axis were investigated. 10 and 25 mg GA/kg were administered orally to sexually mature adult male Wistar rats for 4 and 5 weeks, respectively. STH and LTH/PRL cells showed no significant changes as compared to those of controls whi...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(92)90162-m

    authors: Udoh P,Patil DR,Deshpande MK

    更新日期:1992-05-01 00:00:00

  • A Bridge for postpartum women to Standard Days Method®: I. Developing the Bridge.

    abstract:BACKGROUND:A new fertility-awareness-based Bridge was developed for postpartum women starting with their first postpartum menses and until they are eligible to use the Standard Days Method®. This article describes the development of the Bridge and theoretical efficacy. STUDY DESIGN:Analysis of a preexisting data set c...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2011.11.009

    authors: Sinai I,Cachan J

    更新日期:2012-07-01 00:00:00

  • Pregnancy outcomes associated with extended use of the 52-mg 20 μg/day levonorgestrel-releasing intrauterine system beyond 60 months: A chart review of 776 women in Brazil.

    abstract:OBJECTIVE:To assess the contraceptive performance of the 52-mg 20 μg/day levonorgestrel-releasing intrauterine system (LNG-IUS, Mirena; Bayer Oy, Turku, Finland) among women who maintain the same device without changes after 60 months. STUDY DESIGN:This is a chart review study in which we assessed the charts of 766 wo...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2017.10.007

    authors: Bahamondes L,Fernandes A,Bahamondes MV,Juliato CT,Ali M,Monteiro I

    更新日期:2018-03-01 00:00:00

  • Disturbance of tryptophan metabolism and its correction during hormonal contraception.

    abstract::Blood pyrodoxine hydrochloride (vitamin-B6) concentration was determined in 50 women using combined oral contraceptives (OCs), 24 women who received an intramuscular injection of 150 mg medroxyprogesterone acetate (MPA) every 12 weeks, and in 14 women who used an intrauterine device (IUD) at the out-patient contracep...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/0010-7824(74)90078-x

    authors: Bennink HJ,Schreurs WH

    更新日期:1974-04-01 00:00:00

  • Evaluation of sulprostone for second trimester abortions and its effects on liver and kidney function.

    abstract::Sulprostone was given intramuscularly in two dose schedules of 0.5 mg at 4 hourly intervals for 8 doses and 1.0 mg at 8-hour intervals for 4 doses to 56 women in the 12th-20th week of gestation coming for termination of pregnancy. Forty-nine of them aborted within the 30-hour observation period, giving a success rate ...

    journal_title:Contraception

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1016/0010-7824(82)90028-2

    authors: Ranjan V,Hingorani V,Kinra G,Agarwal N,Pande Y

    更新日期:1982-02-01 00:00:00

  • A single-blinded randomized controlled trial evaluating pain and opioid use after dilator placement for second-trimester abortion.

    abstract:OBJECTIVES:To compare pain levels and medication needs after placement of laminaria vs Dilapan-S, and after dilation and evacuation (D&E). STUDY DESIGN:We conducted a single-blinded randomized control trial of patients undergoing D&E at 15 0/7 to 23 6/7 weeks gestation, randomizing to cervical preparation with laminar...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2020.11.014

    authors: Liu SM,Flink-Bochacki R

    更新日期:2020-12-04 00:00:00

  • Social support in the post-abortion recovery room: evidence from patients, support persons and nurses in a Vancouver clinic.

    abstract:BACKGROUND:The benefits of social support in post-surgical recovery are well documented; social support decreases preoperative stress and postoperative recovery time. However, a paucity of studies have examined the effect of social support in the context of pregnancy termination. This study is the first to examine the ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2010.07.019

    authors: Veiga MB,Lam M,Gemeinhardt C,Houlihan E,Fitzsimmons BP,Hodgson ZG

    更新日期:2011-03-01 00:00:00

  • Interest in and experience with IUD self-removal.

    abstract:OBJECTIVES:In the United States, the popularity of intrauterine devices (IUDs) is low despite many positive attributes such as high effectiveness and ease of use. The requirement that a clinician remove the IUD may limit US women's interest in the method. Our objective was to describe women's experience with self-remov...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2014.01.025

    authors: Foster DG,Grossman D,Turok DK,Peipert JF,Prine L,Schreiber CA,Jackson AV,Barar RE,Schwarz EB

    更新日期:2014-07-01 00:00:00

  • The relationship between source of sexual information and sexual behavior among female adolescents.

    abstract:INTRODUCTION:The relationship between the source of sexual information and adolescent sexual behavior is not well understood. MATERIALS AND METHODS:As part of a larger study, 892 sexually active female adolescents between 15 and 18 years of age completed a paper-and-pencil survey which assessed discussions about sexua...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2005.08.014

    authors: Berenson AB,Wu ZH,Breitkopf CR,Newman J

    更新日期:2006-03-01 00:00:00

  • Insertion and 3-year follow-up experience of 372 etonogestrel subdermal contraceptive implants by family physicians in Granada, Spain.

    abstract:BACKGROUND:User profile, continuation rate, reasons for discontinuation, problems during insertion and removal, and effectiveness of an etonogestrel subdermal contraceptive implant (ESCI) were assessed. STUDY DESIGN:A follow-up of 372 women 3 years after insertion of an ESCI performed by family physicians in Granada, ...

    journal_title:Contraception

    pub_type: 杂志文章

    doi:10.1016/j.contraception.2009.04.003

    authors: Arribas-Mir L,Rueda-Lozano D,Agrela-Cardona M,Cedeño-Benavides T,Olvera-Porcel C,Bueno-Cavanillas A

    更新日期:2009-11-01 00:00:00